Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion Provision

Recruiting N/A Interventional Study
Sexually Transmitted Disease (STD) Gonorrhea Chlamydia Trichomonas Infection
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
14 and older
Sex
Female
Study type
Interventional
Purpose
Health Services Research
Participants needed
75 (estimated)
Sponsor
Queen's Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this interventional study is to provide more access to STI testing for patients who seek abortion care through telemedicine, particularly for those whose access to STI testing is otherwise limited. The main questions it aims to answer are: What is the acceptability, feasibility, and utilization of self-collected STI screening at the time of telemedicine medication abortion provision? …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patients of the Queen Medical Center Options Center clinic seeking telemedicine medication abortion. 2. Patients for whom, according to the CDC guidelines for STI Testing11, STI testing is indicated, or patients who desire STI screening 3. Age 14 and over 4. Can speak and rea…
Contacts

Olivia H Manayan, MD, MPH

808-348-7859

omanayan@hawaii.edu

CONTACT